The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R, Liew SH, Connelly AA, Yee NS, Deb S, Kumar B, Vargas AC, O'Toole SA, Parslow AC, Poh A, Putoczki T, Morrow RJ, Alorro M, Lazarus KA, Yeap EFW, Walton KL, Harrison CA, Hannan NJ, George AJ, Clyne CD, Ernst M, Allen AM, Chand AL.
Coulson R, et al. Among authors: chand al.
Oncotarget. 2017 Mar 21;8(12):18640-18656. doi: 10.18632/oncotarget.15553.
Oncotarget. 2017.
PMID: 28416734
Free PMC article.